No more needles? new insulin spray could change diabetes care
NCT ID NCT05159453
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new way to deliver insulin for type 2 diabetes: a spray applied to the skin instead of an injection. Thirty adults who already use insulin will try the spray for 21 days. Researchers will check if it keeps blood sugar in a safe range and causes less skin irritation or low blood sugar events compared to standard injected insulin.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Human insulin (same as injected insulin, but delivered through the skin via a spray)
What this could lead to
If it works, this could offer a needle-free way to deliver insulin for people with type 2 diabetes, making daily management easier and less painful.
What could go wrong
This is a small, early-stage trial with only 30 people for 21 days. The skin spray may not deliver insulin reliably or could cause skin irritation. It is not yet proven to be as effective as injections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Langford Research Institute
Palm Beach Gardens, Florida, 33410, United States